Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (14)

2021

  1. 2-phenoxy-3-trichloromethylquinoxalines are antiplasmodial derivatives with activity against the apicoplast of plasmodium falciparum

    Pharmaceuticals, Vol. 14, Núm. 8

2019

  1. Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 10, pp. 1405-1414

2017

  1. Model description language (MDL): A standard for modeling and simulation

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 6, Núm. 10, pp. 647-650

2012

  1. Brain drug delivery systems for neurodegenerative disorders

    Current Pharmaceutical Biotechnology, Vol. 13, Núm. 12, pp. 2388-2402

2011

  1. Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety

    Journal of Chemical Neuroanatomy, Vol. 41, Núm. 4, pp. 227-233

  2. Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers

    Journal of Neurochemistry, Vol. 119, Núm. 5, pp. 972-988

  3. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats

    Biomaterials, Vol. 32, Núm. 6, pp. 1560-1573

2008

  1. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes

    Bioconjugate Chemistry, Vol. 19, Núm. 12, pp. 2385-2393

2005

  1. Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

    Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 3, pp. 293-305

2004

  1. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes

    Bioconjugate Chemistry, Vol. 15, Núm. 3, pp. 541-553

2002

  1. Adaptive immune responses of legumin nanoparticles

    Journal of Drug Targeting, Vol. 10, Núm. 8, pp. 625-631

  2. Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells

    Journal of Drug Targeting, Vol. 10, Núm. 3, pp. 231-238

  3. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats

    Biomaterials, Vol. 23, Núm. 7, pp. 1587-1594

2000

  1. Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography

    Journal of Chromatography A, Vol. 870, Núm. 1-2, pp. 159-167